Dr. Mamlouk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6431 Fannin Street
Houston, TX 77030- Is this information wrong?
Education & Training
- Jordan University of Science and Technology FOMClass of 2009
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- TX State Medical License 2019 - 2026
- TN State Medical License 2023 - 2026
- LA State Medical License 2023 - 2025
- WA State Medical License 2023 - 2025
- GA State Medical License 2024 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
- Join now to see all
Publications & Presentations
PubMed
- Immune Checkpoint Inhibitor-Associated Nephrotoxicity.Omar Mamlouk, Farhad R Danesh> ;Nephron. 2024 Jan 1
- Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response.Vishnupriyadevi Parvathareddy, Umut Selamet, Aditi A Sen, Omar Mamlouk, Juhee Song, Valda D Page, Maen Abdelrahim, Adi Diab, Noha Abdel-Wahab, Ala Abudayyeh> ;Cancers. 2023 Oct 27
- 2 citationsPathologic Predictors of Response to Treatment of Immune Checkpoint Inhibitor-Induced Kidney Injury.Ala Abudayyeh, Liye Suo, Heather Lin, Omar Mamlouk, Noha Abdel-Wahab, Amanda Tchakarov> ;Cancers. 2022 Oct 27
- Join now to see all
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: